Abstract:OBJECTIVEHepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatic arterial chemoembolization transcatheter (TACE) is one of the main treatment methods for liver cancer. However, the long-term therapeutic effect of HCC after TACE is still unsatisfactory, postoperative recurrence and metastasis rate is still very high. Furthermore, TACE operation due to liver cancer tissue ischemia and hypoxia will lead to up-regulation of vascular endothelial growth factor (VEGF) expression. In the current study, we investigated the effects of suppressed VEGF on HCC and its molecular mechanism provided a basis for targeting angiogenesis.MATERIALS AND METHODSWe established rabbits primary HCC model by in situ embedding the VX2 subcutaneous transplantation tumor. Conventional Seldinger femoral artery and hepatic artery catheterization method were used to select the catheter over the tumor-bearing hepatic artery. The different groups were divided into TACE operation, and the experimental group was performed with the VEGF-siRNA molecular preparation in the catheter. 64-slice spiral CT were used to perfusion imaging of liver cancer model before and after TACE operation. We further assessed the efficiency of VEGF silencing and its influence on VX2 cells. The expression of VEGF mRNA and protein were detected by RT-PCR and Western blotting, respectively. Intratumoral microvessel density (MVD), VEGF and CD34 were evaluated by immunohistochemistry. We detected the cell apoptotic by immunofluorescence and flow cytometry.RESULTSOur findings indicated that VEGF-siRNA-2# could effectively suppress the expression of VEGF expression, inhibited the proliferation capability and promoted apoptosis of VX2 cells in vitro. Silencing of VEGF expression also suppress HCC tumor growth and reduce HCC angiogenesis in rabbits primary HCC model in vivo. Furthermore, We found that phosphoinositide 3-kinase (PI3K) and protein kinase B (AKT) activation were considerably reduced while inhibition VEGF expression in VX2 cells.CONCLUSIONSOur data demonstrated that VEGF silencing could suppress cells proliferation, promote cells apoptosis and reduce HCC angiogenesis through inactivation of VEGF/PI3K/AKT signaling pathway.

Autocrinism of vascular endothelial growth factor in human hepatocellular carcinoma cell and its significance

[Autocrine Effect of Vascular Endothelial Growth Factor on the Proliferation of HaCaT Cells].

[Expression of Vascular Endothelial Growth Factor and Its Receptors in Laryngeal Carcinoma Cell and Its Significance].

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

Effects of Autocrine Vascular Endothelial Growth Factor (VEGF) in Non-Small Cell Lung Cancer Cell Line A549.

Expression of Vascular Endothelial Growth Factor (VEGF) and Its Receptors in Human Hepatocellular Carcinoma Cell Lines

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

[The Expression and Significance of Vascular Endothelial Growth Factor and Its Receptors in Hepatocellular Carcinoma Cell Lines with Various Metastatic Potentialities].

The expression of vascular endothelial cadherin and vascular endothelial growth factor in hepatocellular carcinoma and its impact on vascular endothelial cells

Detection of VEGF and VEGFR in Human Hepatoma Cell Lines and the Investigation on Its Significance

Effect of VEGF165b on biological characteristics of human hepatocellular carcinoma HepG2 cells

Expression of Vascular Endothelial Growth Factor (VEGF) and Its Receptor KDR in Hepatocellular Carcinoma

Vascular endothelial growth factor receptor-1 promotes migration and invasion of hepatocellular carcinoma cell lines

Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial To Mesenchymal Transition In Hepatocellular Carcinoma Cells

Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.

Expression of Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma: Impact on Neovascularization and Survival

Hepatocyte Nuclear Factor 4α Inhibits Expression of Vascular Endothelial Growth Factor in Human Hepatocellular Carcinoma Cell Lines and Tube Formation of Human Umbilical Vein Endothelial Cell

The Molecular Mechanism Underlying Angiogenesis in Hepatocellular Carcinoma: the Imbalance Activation of Signaling Pathways.

Advancement of the relationship between vascular endothelial growth factor receptors and angiogenesis of hepatocellular carcinoma